ACTH 1-17 effects in oncology. 1984

T Battelli, and R Mattioli, and P Manocchi, and L Giustini, and A Ginnetti, and L Burattini

Since November 1981, 90 cancer patients treated with cytotoxic chemotherapy (CMF, FAC, FAM) have been studied to evaluate whether the administration of Synchrodyn 1-17, 100 micrograms i.m. a day for 15 consecutive days, could reduce some side effects caused by the cytotoxic drugs. Nausea, vomiting and weakness which are the most frequent side effects generally found to be very upsetting to patients, were less pronounced in the treated patients than in patients treated with a placebo. The performance status was not modified by the treatment. Skin pigmentation was noted in the majority of cases and it appeared to be related to the sustained treatment with high dosages of the peptide. Some side effects were observed in the treated patients such as sodium retention and hypertension, hyperglycemia. Successively we have begun to study the circadian rhythm of the cortisol, which often changes during the advanced stages of the illness and which chemotherapy does not seem to alter.

UI MeSH Term Description Entries
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D010446 Peptide Fragments Partial proteins formed by partial hydrolysis of complete proteins or generated through PROTEIN ENGINEERING techniques. Peptide Fragment,Fragment, Peptide,Fragments, Peptide
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000324 Adrenocorticotropic Hormone An anterior pituitary hormone that stimulates the ADRENAL CORTEX and its production of CORTICOSTEROIDS. ACTH is a 39-amino acid polypeptide of which the N-terminal 24-amino acid segment is identical in all species and contains the adrenocorticotrophic activity. Upon further tissue-specific processing, ACTH can yield ALPHA-MSH and corticotrophin-like intermediate lobe peptide (CLIP). ACTH,Adrenocorticotropin,Corticotropin,1-39 ACTH,ACTH (1-39),Adrenocorticotrophic Hormone,Corticotrophin,Corticotrophin (1-39),Corticotropin (1-39),Hormone, Adrenocorticotrophic,Hormone, Adrenocorticotropic
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy

Related Publications

T Battelli, and R Mattioli, and P Manocchi, and L Giustini, and A Ginnetti, and L Burattini
January 1984, La Ricerca in clinica e in laboratorio,
T Battelli, and R Mattioli, and P Manocchi, and L Giustini, and A Ginnetti, and L Burattini
January 1984, La Ricerca in clinica e in laboratorio,
T Battelli, and R Mattioli, and P Manocchi, and L Giustini, and A Ginnetti, and L Burattini
January 1984, La Ricerca in clinica e in laboratorio,
T Battelli, and R Mattioli, and P Manocchi, and L Giustini, and A Ginnetti, and L Burattini
January 1984, La Ricerca in clinica e in laboratorio,
T Battelli, and R Mattioli, and P Manocchi, and L Giustini, and A Ginnetti, and L Burattini
January 1984, La Ricerca in clinica e in laboratorio,
T Battelli, and R Mattioli, and P Manocchi, and L Giustini, and A Ginnetti, and L Burattini
January 1984, La Ricerca in clinica e in laboratorio,
T Battelli, and R Mattioli, and P Manocchi, and L Giustini, and A Ginnetti, and L Burattini
January 1984, La Ricerca in clinica e in laboratorio,
T Battelli, and R Mattioli, and P Manocchi, and L Giustini, and A Ginnetti, and L Burattini
January 1985, La Ricerca in clinica e in laboratorio,
T Battelli, and R Mattioli, and P Manocchi, and L Giustini, and A Ginnetti, and L Burattini
August 1987, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme,
T Battelli, and R Mattioli, and P Manocchi, and L Giustini, and A Ginnetti, and L Burattini
January 1984, La Ricerca in clinica e in laboratorio,
Copied contents to your clipboard!